Vanderbilt-Ingram Cancer Center Archive — Page 7 of 28

color-enhanced cross section of tumor tissue
October 7, 2024

New Video: Study shows cancer vaccine blocks tumor progression at early lesion stage

Senior author Mary Philip, MD, PhD, associate director of the Vanderbilt Institute for Infection, Immunology and Inflammation, talks about her Journal for ImmunoTherapy of Cancer study.
The findings support further vaccine investigation to make long-term, progression-free survival a reality for more cancer patients.

October 7, 2024

VUMC hosts International Lung Cancer Consortium meeting 

The consortium is coordinated by the International Agency for Research on Cancer with the aim of sharing data from ongoing lung cancer case-control and cohort studies.

(iStock)
October 4, 2024

‘Off-the-shelf’ CAR-T therapy shows promise for relapsed/refractory multiple myeloma 

The therapy, P-BCMA-ALL01, demonstrated a 91% overall response rate for the 23 patients participating in the phase 1 trial.

October 3, 2024

DAISY Award spotlight: ‘She has been there so many times for my husband and me.’

Jenny Meier, RN, works in the Vanderbilt-Ingram Cancer Center. She is one of the latest DAISY Award winners at VUMC.

Clip in 4 the Cure was held at Geodis Park on Saturday, Sept. 14.
October 2, 2024

Clip In 4 the Cure

The high-energy fundraiser began in 2022 to raise money for cancer initiatives at Vanderbilt-Ingram Cancer Center and Monroe Carell Jr. Children’s Hospital at Vanderbilt.

October 2, 2024

Grant funds quest to expand immunotherapy efficacy for colorectal cancer  

The study seeks to understand the mechanisms of colorectal cancer and builds on recent Vanderbilt research.